Newly Approved Drug Therapies (320): Ranitidine Capsules, Geneva Pharmaceuticals

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: Ranitidine Capsules

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Geneva Pharmaceuticals
Approval Status: Approved October 1997
Treatment for: heartburn

General Information

Ranitidine Capsules is the generic version of Zantac GELdose, a treatment for heartburn and indigestion. Geneva will begin shipping 150 and 300 mg dosages immediately. Geneva is part of the Global Generics sector of Novartis.

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]